RhumbLine Advisers’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Sell
148,408
-18,452
-11% -$435K ﹤0.01% 1717
2026
Q1
$3.8M Buy
166,860
+4,443
+3% +$105K ﹤0.01% 1535
2025
Q4
$4.33M Sell
162,417
-10,606
-6% -$313K ﹤0.01% 1469
2025
Q3
$5.25M Buy
173,023
+682
+0.4% +$20.7K ﹤0.01% 1416
2025
Q2
$5.4M Buy
172,341
+42,138
+32% +$1.39M ﹤0.01% 1373
2025
Q1
$4.98M Sell
130,203
-22,425
-15% -$951K ﹤0.01% 1360
2024
Q4
$6.7M Buy
152,628
+1,938
+1% +$85.1K 0.01% 1268
2024
Q3
$6.49M Buy
150,690
+10,409
+7% +$464K 0.01% 1280
2024
Q2
$6.34M Sell
140,281
-1,891
-1% -$98.1K 0.01% 1262
2024
Q1
$8.88M Sell
142,172
-6,795
-5% -$407K 0.01% 1111
2023
Q4
$8.35M Sell
148,967
-4,058
-3% -$202K 0.01% 1147
2023
Q3
$8.07M Sell
153,025
-3,022
-2% -$176K 0.01% 1093
2023
Q2
$10M Buy
156,047
+9,448
+6% +$538K 0.01% 1012
2023
Q1
$7.84M Sell
146,599
-1,627
-1% -$94.3K 0.01% 1081
2022
Q4
$7.93M Buy
148,226
+7,628
+5% +$394K 0.01% 1046
2022
Q3
$6.48M Buy
140,598
+4,451
+3% +$241K 0.01% 1100
2022
Q2
$7.49M Sell
136,147
-71,009
-34% -$4.58M 0.01% 1054
2022
Q1
$14.2M Buy
207,156
+6,483
+3% +$462K 0.02% 764
2021
Q4
$15.9M Buy
200,673
+8,209
+4% +$687K 0.02% 723
2021
Q3
$15.2M Buy
192,464
+13,316
+7% +$1.07M 0.02% 735
2021
Q2
$14.1M Buy
179,148
+8,975
+5% +$687K 0.02% 803
2021
Q1
$12.8M Buy
170,173
+13,422
+9% +$984K 0.02% 842
2020
Q4
$10.3M Buy
156,751
+7,264
+5% +$425K 0.01% 903
2020
Q3
$8.07M Buy
149,487
+11,577
+8% +$636K 0.01% 882
2020
Q2
$6.62M Buy
137,910
+4,731
+4% +$209K 0.01% 1026
2020
Q1
$4.54M Buy
133,179
+11,750
+10% +$646K 0.01% 1074
2019
Q4
$7.6M Buy
121,429
+2,924
+2% +$165K 0.01% 1004
2019
Q3
$5.93M Sell
118,505
-10,600
-8% -$500K 0.01% 1097
2019
Q2
$6.23M Buy
129,105
+3,226
+3% +$155K 0.01% 1073
2019
Q1
$6.43M Buy
125,879
+79,613
+172% +$3.49M 0.01% 1031
2018
Q4
$1.66M Sell
46,266
-1,508
-3% -$70.4K ﹤0.01% 1760
2018
Q3
$2.96M Sell
47,774
-1,261
-3% -$71.8K 0.01% 1435
2018
Q2
$2.59M Buy
49,035
+369
+0.8% +$19.9K 0.01% 1524
2018
Q1
$2.67M Buy
48,666
+339
+0.7% +$20.9K 0.01% 1436
2017
Q4
$3.3M Sell
48,327
-87
-0.2% -$5.86K 0.01% 1322
2017
Q3
$3.47M Buy
48,414
+306
+0.6% +$21.3K 0.01% 1260
2017
Q2
$3.26M Sell
48,108
-7,859
-14% -$536K 0.01% 1263
2017
Q1
$3.78M Buy
55,967
+2,962
+6% +$197K 0.01% 1179
2016
Q4
$3.28M Buy
53,005
+6,075
+13% +$359K 0.01% 1160
2016
Q3
$2.54M Buy
46,930
+2,177
+5% +$110K 0.01% 1258
2016
Q2
$2.04M Buy
44,753
+3,829
+9% +$187K 0.01% 1330
2016
Q1
$2.01M Sell
40,924
-1,150
-3% -$48.9K 0.01% 1374
2015
Q4
$1.69M Buy
42,074
+3,381
+9% +$155K 0.01% 1463
2015
Q3
$1.99M Buy
38,693
+2,569
+7% +$170K 0.01% 1318
2015
Q2
$2.87M Sell
36,124
-9,702
-21% -$822K 0.01% 1171
2015
Q1
$3.77M Buy
45,826
+1,517
+3% +$127K 0.01% 997
2014
Q4
$3.93M Sell
44,309
-134
-0.3% -$12.1K 0.01% 924
2014
Q3
$4.36M Buy
44,443
+4
+0% +$449 0.01% 840
2014
Q2
$5.7M Sell
44,439
-334
-0.7% -$41.7K 0.02% 741
2014
Q1
$5.5M Buy
44,773
+3,062
+7% +$352K 0.02% 776
2013
Q4
$4.57M Sell
41,711
-4,207
-9% -$421K 0.01% 864
2013
Q3
$4.46M Sell
45,918
-859
-2% -$79.2K 0.01% 860
2013
Q2
$4.2M Buy
+46,777
New +$3.86M 0.01% 858

Other funds holding ENOV

RhumbLine Advisers's ENOV Position: Q2 2026 in Review

RhumbLine Advisers reduced its Enovis (ENOV) stake by 11% in Q2 2026, selling an estimated $435K and leaving 148,408 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

RhumbLine Advisers first reported a position in ENOV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.9M in Q4 2021. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • RhumbLine Advisers held 148,408 shares of Enovis worth $3.07M as of Q2 2026.
  • RhumbLine Advisers sold 18,452 Enovis shares in Q2 2026, an estimated $435K.
  • Enovis made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1717 holding.
  • RhumbLine Advisers first reported a position in Enovis in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Enovis position peaked at $15.9M in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.